Fjordland Expl Inc (FEXXF) 0.0989 $FEXXF Fjordland

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fjordland Expl Inc (FEXXF) 0.0989 $FEXXF

Fjordland Announces Appointment of Kolebaba as Adviser
Newsfile Corp - Mon Jun 20, 8:20AM CDT
full story)
FEX.VN: 0.125 (unch)

CanAlaska Options Additional Claims for Diamond Exploration in the Northwestern Athabasca
ACCESSWIRE - Fri May 27, 9:55AM CDT
VANCOUVER, BC / ACCESSWIRE / May 27, 2016 / CanAlaska Uranium Ltd. (TSXV: CVV) (OTCQB: CVVUF) (FSE: DH7N), is pleased to report that it has optioned two claim groups for diamond exploration to Fjordland Exploration Inc. The two claims comprising 449 hectares and 2045 hectares respectively, were recently staked by the Company, and are located east of the claims CanAlaska optioned to De Beers Canada Inc. in the Northwestern Athabasca Basin, Saskatchewan (see May 18, 2016 news release). The option deals with De Beers and Fjordland collectively comprise eighty-four (84) kimberlite-style targets.
CVV.VN: 1.450 (+0.140)

Fjordland Options Athabasca Basin Claims With Potential Kimberlite Targets, from CanAlaska
ACCESSWIRE - Tue May 24, 7:25PM CDT
VANCOUVER, BC / ACCESSWIRE / May 24, 2016 / Fjordland Exploration Inc. (TSXV: FEX) has executed an Option to Purchase Agreement ("Agreement" with CanAlaska Uranium Ltd. ("CanAlaska" whereby Fjordland has the option to purchase a 100% interest in two claim groups recently staked by CanAlaska in the Northwestern Athabasca Basin, Saskatchewan. See map at http://www.fjordlandex.com/galleries/westa1.html
FEX.VN: 0.125 (unch)

Fjordland Stakes Additional Claims surrounding Kimberlite Targets in Athabasca Basin
ACCESSWIRE - Thu May 19, 8:40AM CDT
VANCOUVER, BC / ACCESSWIRE / May 19, 2016 / Fjordland Exploration Inc. (TSXV: FEX) has staked an additional 40,000 hectares of claims for a total of 84,809 hectares surrounding the recently announced DeBeers Canada Inc. ("DeBeers" / CanAlaska Uranium Ltd. ("CanAlaska" project in the northwestern part of the Athabasca Basin in Saskatchewan.
FEX.VN: 0.125 (unch)

Fjordland Cancels Non-Brokered Private Placement
ACCESSWIRE - Mon Oct 05, 8:38AM CDT
VANCOUVER, BC / ACCESSWIRE / October 5, 2015 / Fjordland Exploration Inc. (TSXV: FEX) announces it will not be proceeding with the financing announced on June 19, 2015. Proceeds of this financing were intended to fund the initial drill testing of several highly encouraging UTEM anomalies recently identified on the South Voisey's Bay Copper-Nickel-Cobalt Project. Due to climate, the drilling season in Labrador for this time of year is drawing to a close and the Company would not be able to complete the planned drill program without incurring additional costs related to weather. The Company has earned 15% interest in the project and intends to participate in future exploration programs proposed by the operator, Commander Resources Ltd.
FEX.VN: 0.125 (unch)

Fjordland Announces Non-Brokered Private Placement
Newsfile Corp - Fri Jun 19, 1:40PM CDT
full story)
FEX.VN: 0.125 (unch)

BUYINS.NET: UPRO, PRTS, DRW, HGG, FEX, LVL Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Mon Apr 27, 7:03AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of ProShares UltraPro S&P 500 (NYSE:UPRO), US Auto Parts Network Inc (NASDAQ RTS), WisdomTree Global ex-US Real Estate Fund (NYSE RW), HHGREGG Inc (NYSE:HGG), Fjordland Exploration Inc (NYSE:FEX), Lynden Energy Corp (NYSE:LVL) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:
LVL: 9.48 (+0.25), FEX: 45.68 (+0.82), UPRO: 69.58 (+2.95), DRW: 27.35 (+0.52), PRTS: 4.17 (+0.17), HGG: 1.88 (+0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading